Niva Russek- Blum

Chief Technology Officer at NeuroSense Therapeutics (NASDAQ: NRSN), developing novel combination therapies for neurodegenerative diseases. 10 years of leading research and managerial experience as a Principle Investigator under the auspices of Ben Gurion University, focusing on neurological and immune perspectives of neurodegenerative diseases. Translational research, utilizing high throughput-screening infrastructure required for the evaluation of potential therapeutics, with broad expertise in microscopy, image and behavioral analyses. Experienced in raising funds, collaborating with major academia and biotech/pharma entities, managing strategic planning, recruiting and mentoring students and technical staff and cooperating with TTOs. Neuroscientist with over 18 years of experience. Ph.D. in Neurobiology, from The Weizmann Institute of Science.